Cargando…
Nanomedicine and drug delivery to the retina: current status and implications for gene therapy
Blindness affects more than 60 million people worldwide. Retinal disorders, including age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma, are the leading causes of blindness. Finding means to optimize local and sustained delivery of drugs or genes to the eye and retina i...
Autores principales: | Tawfik, Mohamed, Chen, Fang, Goldberg, Jeffrey L., Sabel, Bernhard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630211/ https://www.ncbi.nlm.nih.gov/pubmed/36107200 http://dx.doi.org/10.1007/s00210-022-02287-3 |
Ejemplares similares
-
Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics
por: Choi, Young Hee, et al.
Publicado: (2017) -
Correction to: Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics
por: Choi, Young Hee, et al.
Publicado: (2018) -
Nanoparticles as a tool to deliver drugs to the retina and brain: an update
por: You, Qing, et al.
Publicado: (2020) -
The potential of nanomedicine therapies to treat neovascular disease in the retina
por: Farjo, Krysten M, et al.
Publicado: (2010) -
Current status of nanomedicine and nanosurgery
por: Singh, Sanjeev, et al.
Publicado: (2013)